0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blepharitis Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-17Z9254
Home | Market Reports | Health| Vision Care
Global Blepharitis Market Size Status and Forecast 2022
BUY CHAPTERS

Global Blepharitis Market Research Report 2026

Code: QYRE-Auto-17Z9254
Report
2026-02-26
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blepharitis Market Size

The global Blepharitis market was valued at US$ 1704 million in 2025 and is anticipated to reach US$ 2279 million by 2032, at a CAGR of 4.3% from 2026 to 2032.

Blepharitis Market

Blepharitis Market

Blepharitis is an inflammation of the eyelids in which they become red, irritated and itchy and dandruff-like scales form on the eyelashes. It is a common eye disorder caused by either bacteria or a skin condition, such as dandruff of the scalp or rosacea. It affects people of all ages. Although uncomfortable, blepharitis is usually not contagious and generally does not cause any permanent damage to eyesight.
Market competition is intense. Bausch Health, Allergan, Novartis LABORATORIES THEA, etc. are the leaders of the industry. They hold key technologies and patents, with high-end customers, but only occupied 24.39% market share.
This report delivers a comprehensive overview of the global Blepharitis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blepharitis. The Blepharitis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blepharitis market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blepharitis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Blepharitis Market Report

Report Metric Details
Report Name Blepharitis Market
Accounted market size in 2025 US$ 1704 million
Forecasted market size in 2032 US$ 2279 million
CAGR 4.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Antibiotics
  • Steroids
  • Other
Segment by Application
  • Monotherapy
  • Combination Drug Therapy
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Blepharitis companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Blepharitis Market growing?

Ans: The Blepharitis Market witnessing a CAGR of 4.3% during the forecast period 2026-2032.

What is the Blepharitis Market size in 2032?

Ans: The Blepharitis Market size in 2032 will be US$ 2279 million.

Who are the main players in the Blepharitis Market report?

Ans: The main players in the Blepharitis Market are Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics

What are the Application segmentation covered in the Blepharitis Market report?

Ans: The Applications covered in the Blepharitis Market report are Monotherapy, Combination Drug Therapy

What are the Type segmentation covered in the Blepharitis Market report?

Ans: The Types covered in the Blepharitis Market report are Antibiotics, Steroids, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blepharitis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Antibiotics
1.2.3 Steroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global Blepharitis Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Monotherapy
1.3.3 Combination Drug Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blepharitis Market Perspective (2021–2032)
2.2 Global Blepharitis Growth Trends by Region
2.2.1 Global Blepharitis Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Blepharitis Historic Market Size by Region (2021–2026)
2.2.3 Blepharitis Forecasted Market Size by Region (2027–2032)
2.3 Blepharitis Market Dynamics
2.3.1 Blepharitis Industry Trends
2.3.2 Blepharitis Market Drivers
2.3.3 Blepharitis Market Challenges
2.3.4 Blepharitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blepharitis Players by Revenue
3.1.1 Global Top Blepharitis Players by Revenue (2021–2026)
3.1.2 Global Blepharitis Revenue Market Share by Players (2021–2026)
3.2 Global Top Blepharitis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Blepharitis Revenue
3.4 Global Blepharitis Market Concentration Ratio
3.4.1 Global Blepharitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blepharitis Revenue in 2025
3.5 Global Key Players of Blepharitis Head Offices and Areas Served
3.6 Global Key Players of Blepharitis, Products and Applications
3.7 Global Key Players of Blepharitis, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Blepharitis Breakdown Data by Type
4.1 Global Blepharitis Historic Market Size by Type (2021–2026)
4.2 Global Blepharitis Forecasted Market Size by Type (2027–2032)
5 Blepharitis Breakdown Data by Application
5.1 Global Blepharitis Historic Market Size by Application (2021–2026)
5.2 Global Blepharitis Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Blepharitis Market Size (2021–2032)
6.2 North America Blepharitis Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Blepharitis Market Size by Country (2021–2026)
6.4 North America Blepharitis Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blepharitis Market Size (2021–2032)
7.2 Europe Blepharitis Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Blepharitis Market Size by Country (2021–2026)
7.4 Europe Blepharitis Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blepharitis Market Size (2021–2032)
8.2 Asia-Pacific Blepharitis Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Blepharitis Market Size by Region (2021–2026)
8.4 Asia-Pacific Blepharitis Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blepharitis Market Size (2021–2032)
9.2 Latin America Blepharitis Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Blepharitis Market Size by Country (2021–2026)
9.4 Latin America Blepharitis Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blepharitis Market Size (2021–2032)
10.2 Middle East & Africa Blepharitis Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Blepharitis Market Size by Country (2021–2026)
10.4 Middle East & Africa Blepharitis Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Blepharitis Introduction
11.1.4 Bausch Health Revenue in Blepharitis Business (2021–2026)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Blepharitis Introduction
11.2.4 Allergan Revenue in Blepharitis Business (2021–2026)
11.2.5 Allergan Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Blepharitis Introduction
11.3.4 Novartis Revenue in Blepharitis Business (2021–2026)
11.3.5 Novartis Recent Development
11.4 LABORATORIES THEA
11.4.1 LABORATORIES THEA Company Details
11.4.2 LABORATORIES THEA Business Overview
11.4.3 LABORATORIES THEA Blepharitis Introduction
11.4.4 LABORATORIES THEA Revenue in Blepharitis Business (2021–2026)
11.4.5 LABORATORIES THEA Recent Development
11.5 Akorn
11.5.1 Akorn Company Details
11.5.2 Akorn Business Overview
11.5.3 Akorn Blepharitis Introduction
11.5.4 Akorn Revenue in Blepharitis Business (2021–2026)
11.5.5 Akorn Recent Development
11.6 NovaBay Pharmaceuticals
11.6.1 NovaBay Pharmaceuticals Company Details
11.6.2 NovaBay Pharmaceuticals Business Overview
11.6.3 NovaBay Pharmaceuticals Blepharitis Introduction
11.6.4 NovaBay Pharmaceuticals Revenue in Blepharitis Business (2021–2026)
11.6.5 NovaBay Pharmaceuticals Recent Development
11.7 Scope Ophthalmics
11.7.1 Scope Ophthalmics Company Details
11.7.2 Scope Ophthalmics Business Overview
11.7.3 Scope Ophthalmics Blepharitis Introduction
11.7.4 Scope Ophthalmics Revenue in Blepharitis Business (2021–2026)
11.7.5 Scope Ophthalmics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Blepharitis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Antibiotics
 Table 3. Key Players of Steroids
 Table 4. Key Players of Other
 Table 5. Global Blepharitis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Blepharitis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Blepharitis Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Blepharitis Market Share by Region (2021–2026)
 Table 9. Global Blepharitis Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Blepharitis Market Share by Region (2027–2032)
 Table 11. Blepharitis Market Trends
 Table 12. Blepharitis Market Drivers
 Table 13. Blepharitis Market Challenges
 Table 14. Blepharitis Market Restraints
 Table 15. Global Blepharitis Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Blepharitis Market Share by Players (2021–2026)
 Table 17. Global Top Blepharitis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blepharitis Revenue, 2025
 Table 18. Ranking of Global Top Blepharitis Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Blepharitis Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Blepharitis, Headquarters and Area Served
 Table 21. Global Key Players of Blepharitis, Products and Applications
 Table 22. Global Key Players of Blepharitis, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Blepharitis Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Blepharitis Revenue Market Share by Type (2021–2026)
 Table 26. Global Blepharitis Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Blepharitis Revenue Market Share by Type (2027–2032)
 Table 28. Global Blepharitis Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Blepharitis Revenue Market Share by Application (2021–2026)
 Table 30. Global Blepharitis Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Blepharitis Revenue Market Share by Application (2027–2032)
 Table 32. North America Blepharitis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Blepharitis Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Blepharitis Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Blepharitis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Blepharitis Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Blepharitis Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Blepharitis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Blepharitis Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Blepharitis Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Blepharitis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Blepharitis Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Blepharitis Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Blepharitis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Blepharitis Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Blepharitis Market Size by Country (US$ Million), 2027–2032
 Table 47. Bausch Health Company Details
 Table 48. Bausch Health Business Overview
 Table 49. Bausch Health Blepharitis Product
 Table 50. Bausch Health Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 51. Bausch Health Recent Development
 Table 52. Allergan Company Details
 Table 53. Allergan Business Overview
 Table 54. Allergan Blepharitis Product
 Table 55. Allergan Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 56. Allergan Recent Development
 Table 57. Novartis Company Details
 Table 58. Novartis Business Overview
 Table 59. Novartis Blepharitis Product
 Table 60. Novartis Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 61. Novartis Recent Development
 Table 62. LABORATORIES THEA Company Details
 Table 63. LABORATORIES THEA Business Overview
 Table 64. LABORATORIES THEA Blepharitis Product
 Table 65. LABORATORIES THEA Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 66. LABORATORIES THEA Recent Development
 Table 67. Akorn Company Details
 Table 68. Akorn Business Overview
 Table 69. Akorn Blepharitis Product
 Table 70. Akorn Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 71. Akorn Recent Development
 Table 72. NovaBay Pharmaceuticals Company Details
 Table 73. NovaBay Pharmaceuticals Business Overview
 Table 74. NovaBay Pharmaceuticals Blepharitis Product
 Table 75. NovaBay Pharmaceuticals Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 76. NovaBay Pharmaceuticals Recent Development
 Table 77. Scope Ophthalmics Company Details
 Table 78. Scope Ophthalmics Business Overview
 Table 79. Scope Ophthalmics Blepharitis Product
 Table 80. Scope Ophthalmics Revenue in Blepharitis Business (US$ Million), 2021–2026
 Table 81. Scope Ophthalmics Recent Development
 Table 82. Research Programs/Design for This Report
 Table 83. Key Data Information from Secondary Sources
 Table 84. Key Data Information from Primary Sources
 Table 85. Authors List of This Report


List of Figures
 Figure 1. Blepharitis Picture
 Figure 2. Global Blepharitis Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Blepharitis Market Share by Type: 2025 vs 2032
 Figure 4. Antibiotics Features
 Figure 5. Steroids Features
 Figure 6. Other Features
 Figure 7. Global Blepharitis Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Blepharitis Market Share by Application: 2025 vs 2032
 Figure 9. Monotherapy Case Studies
 Figure 10. Combination Drug Therapy Case Studies
 Figure 11. Blepharitis Report Years Considered
 Figure 12. Global Blepharitis Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Blepharitis Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Blepharitis Market Share by Region: 2025 vs 2032
 Figure 15. Global Blepharitis Market Share by Players in 2025
 Figure 16. Global Blepharitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Blepharitis Revenue in 2025
 Figure 18. North America Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Blepharitis Market Share by Country (2021–2032)
 Figure 20. United States Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Blepharitis Market Share by Country (2021–2032)
 Figure 24. Germany Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Blepharitis Market Share by Region (2021–2032)
 Figure 32. China Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Blepharitis Market Share by Country (2021–2032)
 Figure 40. Mexico Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Blepharitis Market Share by Country (2021–2032)
 Figure 44. Israel Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Blepharitis Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Bausch Health Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 48. Allergan Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 49. Novartis Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 50. LABORATORIES THEA Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 51. Akorn Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 52. NovaBay Pharmaceuticals Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 53. Scope Ophthalmics Revenue Growth Rate in Blepharitis Business (2021–2026)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc